Natural Alternatives International Europe SA

What Natural Alternatives International Europe SA does

Natural Alternatives International Europe SA (NAIE) is a Swiss-based Contract Development and Manufacturing Organization (CDMO) headquartered in Manno, Ticino, founded in 1999 as the European arm of publicly-listed parent Natural Alternatives International, Inc. (NASDAQ: NAII). NAIE provides end-to-end manufacturing services for nutritional supplements — including custom formulation, blending, encapsulation, tableting, filling, and packaging — out of a ~10,000 sqm Swissmedic GMP-certified facility with 25+ tons per 8-hour blending capacity. The company serves global supplement brands through three distinct commercial models: private-label contract manufacturing (where customers provide formulations), white-label product sales (where NAIE supplies ready-to-market products under the customer's brand), and ingredient licensing through its proprietary CarnoSyn® beta-alanine franchise (CarnoSyn, SR CarnoSyn, TriBsyn, CarnoSyn 4X). NAIE is qualified to the highest industry standards — Swissmedic GMP, FSSC 22000, and the SSCI benchmark required by Walmart, GNC, and Amazon — and was the first company globally to obtain SSCI certification in 2021.

The company generates revenue across four streams: private-label contract manufacturing (the dominant stream, representing ~92% of parent NAI revenue at $164.3M of $178.5M total in FY2021), CarnoSyn® royalty/licensing and raw material sales ($14.2M in FY2021), white-label product sales, and custom formulation R&D services. Pricing is quote-based and not publicly disclosed, with multi-year contracts under a request-for-quote commercial motion. NAIE operates a dual-shore manufacturing model with facilities in Switzerland and parent-operated facilities in Carlsbad/Vista, California, delivering finished products to 40+ countries across Europe, North America, and Asia. The proprietary CarnoSyn® beta-alanine portfolio is the company's key differentiation asset, anchored by FDA NDI status (2019), GRAS self-affirmation (2017), multiple patents, and industry awards.

NAIE's primary customer segments are global supplement brands requiring contract manufacturing, private-label and white-label brands seeking turnkey solutions, and sports nutrition brands sourcing CarnoSyn®-based ingredients. Distribution is direct B2B via field sales across Asia, US, and EU, with a 10-language website and a request-a-quote entry point. Strategically, the company has expanded its format coverage (new sachet and stick lines in 2025), broadened its concept-to-shelf offerings through the 2024 'Finished Products Concept' with named ingredient partners, and qualified to additional certifications (FSSC 22000, December 2024) — all while navigating a notable FY2022 revenue step-down driven by reduced sales to its largest customer.

Name

Natural Alternatives International Europe SA

Legal name

Natural Alternatives International Europe SA

Website

https://naie.ch

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

NAIE is a Swiss-based nutritional supplement CDMO providing custom formulation, private-label and white-label contract manufacturing, and proprietary CarnoSyn® beta-alanine ingredients to global supplement, sports nutrition, and retailer brands across 40+ countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Manno

HQ country

Switzerland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Private-Label Contract Manufacturing: Custom formulation, manufacturing, and packaging of nutritional supplements for private label customers. Sales from this stream represent the majority of company revenue. In FY2021, private-label contract manufacturing sales were $164.3 million out of total $178.5 million net sales. The company provides comprehensive services from concept development to finished product packaging.
2. CarnoSyn® Beta-Alanine Royalty, Licensing and Raw Material Sales: Patented beta-alanine ingredients (CarnoSyn®, SR CarnoSyn®, TriBsyn™, CarnoSyn® 4X) generate royalty, licensing fees, and raw material sales revenue. In FY2021, this stream contributed $14.2 million to total revenue. The company holds FDA NDI status and GRAS self-affirmation for these proprietary ingredients.
3. White Label Product Sales: Sale of pre-formulated, standard products under customer branding. The company provides ready-to-market products including multivitamins, sports nutrition, bone & joint health, immunity, and other supplement categories. Products are sold as-is with customer label applied.
4. Custom Formulation Services: R&D and formulation services where NAIE collaborates with clients to develop new products based on client ideas and company expertise. Services include concept development, ready-to-develop customization of existing formulations, and full contract manufacturing.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

NAIE is a Swiss-based Contract Development and Manufacturing Organization (CDMO) that provides custom formulation, contract manufacturing, quality assurance, and packaging services for nutritional supplements including tablets, capsules, and powder formats. The company serves global supplement brands through private label, white label, and ingredient licensing arrangements, delivering products to more than 40 countries. NAIE also markets its proprietary CarnoSyn beta-alanine ingredient family (CarnoSyn, SR CarnoSyn, TriBsyn, CarnoSyn 4X) through royalty and licensing arrangements.

Product overview

NAIE is a Swiss-based CDMO (Contract Development Manufacturing Organization) specializing in nutritional supplements with a comprehensive service portfolio spanning custom formulation, contract manufacturing, quality assurance, and packaging. The company operates alongside parent company NAI (USA) and offers both Private Label and White Label services. The proprietary CarnoSyn Brands portfolio includes three clinically studied, patented beta-alanine ingredients: CarnoSyn instant release powder, SR CarnoSyn sustained release tablets, and TriBsyn high-bioavailability powder. NAIE White Label offerings include ready-to-market products such as Anti Age C, Collagen Vec, Milk Thistle Plus, NMN 200P4, Omega 3 C, Joint Health C, and others across health categories including multivitamins, sports nutrition, bone health, and immune support.

Differentiator

Problem solved

Functional benefit

Brands

• CarnoSyn®: Clinically studied, patented beta-alanine ingredient for sports nutrition. Includes instant release powder, sustained release tablets, and high-bioavailability formulations.
• SR CarnoSyn®
• TriBsyn™

Products and services

• Custom Formulation R&D scientific expertise and comprehensive formulation knowledge to help develop effective, safe, and market-ready nutritional supplement products. Service is targeted at brands seeking custom formulations tailored to their specifications.
• Contract Manufacturing Full-service manufacturing of nutritional supplements in tablets, capsules, and powder formats with more than 40 years of industry experience. Offered to global supplement brands requiring Swiss-quality contract manufacturing.
• Quality Assurance & Compliance Comprehensive quality control testing including HPLC, dissolution, FT-NIR analysis, and stability studies to ensure product safety and quality. Provided to supplement brands requiring regulatory compliance and certification.
• Packaging Complete turnkey manufacturing and packaging of food and health supplements including bottles, pouches, sachets, sticks, and bulk formats. Service reduces time-to-market and improves cost effectiveness for supplement brands.
• Private Label Custom formulation and manufacturing services allowing brands to develop personalized products under their own brand name with Swiss quality standards. Targeted at private label brands seeking comprehensive CDMO services.
• White Label Ready-to-market standardized products (Anti Age C, Collagen Vec, Milk Thistle Plus, NMN 200P4, Omega 3 C, and others) sold with client's brand label, offering short time-to-market with no R&D costs. Available across multivitamins, sports nutrition, bone health, immunity, and other categories.
• CarnoSyn Beta-Alanine Clinically studied, patented instant release beta-alanine powder for sports nutrition supporting muscle performance, endurance, and recovery. FDA NDI and GRAS status. Licensed and sold as raw ingredient to sports nutrition and supplement brands.
• SR CarnoSyn Patented sustained-release form of beta-alanine designed for higher dosing while supporting wellness and healthy aging applications. Licensed to supplement brands for use in formulations.
• TriBsyn Patent-pending high-bioavailability carnosine booster derived from CarnoSyn beta-alanine with Hydro OleO technology. Paresthesia-free, ideal for ready-to-drink beverages and functional nutrition products. Licensed to supplement brands.
• CarnoSyn 4X Next-generation beta-alanine ingredient engineered for 4x greater bioavailability. Designed for sports nutrition powders, pre-workouts, and performance blends. Provides efficacious dosing without paresthesia with excellent stability, handling, and formulation compatibility.

Quantifiable outcome

• Record fiscal year 2021 with $178.5 million net sales (50.2% increase YoY) and $10.8 million net income
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Ten partnerships are on record, tiered core.

• AstaRealcoreStrategic or Co-development PartnerStrategic ingredient partnership featuring AstaReal astaxanthin for skin beauty applications. NAIE and AstaReal developed finished product concepts with proven benefits and EFSA claims for skin luminosity and beauty-from-within formulations.
• FermentalgcoreStrategic or Co-development PartnerPartnership with Fermentalg for innovative ingredient solutions. Collaboration enables development of premium formulations leveraging branded ingredients for market differentiation.
• FytexiacoreStrategic or Co-development PartnerStrategic partnership with Fytexia for FitFlow concepts combining ingredient expertise with NAIE's manufacturing capabilities. Products support weight management and fitness applications.
• IpronacoreStrategic or Co-development PartnerPartnership with Iprona featuring berry extracts and botanical ingredients for immune support and wellness formulations. Supports NAIE's white label and private label product development.
• LycoredcoreStrategic or Co-development PartnerPartnership with Lycored for advanced carotenoid and lycopene ingredients. Supports development of vision health, skin beauty, and antioxidant supplement formulations.
• Mibelle GroupcoreStrategic or Co-development PartnerPartnership with Mibelle Biochemistry featuring Swiss Skin Beauty Booster technology. Collaboration enables premium anti-aging and skin beauty product development with scientifically backed claims.
• WalmartcoreChannel Partner/ Reseller/ DistributorWalmart, as a member of SSCI (Supplement Safety & Compliance Initiative), requires suppliers to meet SSCI benchmarking standards to sell nutritional supplements on their platforms. NAI/NAIE became the first company to achieve SSCI certification.
• GNCcoreChannel Partner/ Reseller/ DistributorGNC, as a board member of SSCI, participates in establishing quality and compliance standards for nutritional supplements. NAI/NAIE SSCI certification enables product sales through GNC retail locations.
• AmazoncoreChannel Partner/ Reseller/ DistributorAmazon has acknowledged SSCI as a benchmarking standard that companies must meet to sell products on their platform. SSCI certification enables NAIE customers to distribute products through Amazon's e-commerce channels.
• Natural Products Association (NPA)coreStrategic or Co-development PartnerNPA collaborated with leading retailers to create SSCI benchmarking standards. NAI/NAIE participated in this industry-wide effort to establish globally harmonized quality standards for the nutritional supplement supply chain.

Scale indicators10 records

Recent moves15 records

Expansion highlights6 records

Others

• Eurofins Scientific: Eurofins is a global contract laboratory services provider with extensive nutritional supplement, pharmaceutical, and food testing capabilities including HPLC, dissolution, and stability studies — services that overlap with NAIE's in-house QA/QC lab operations. While not a direct manufacturing peer, it is an enabling ecosystem participant serving the same supplement brand customers.

Direct peers

• Glanbia Nutritionals: Glanbia Nutritionals is a global manufacturer of nutritional premixes, proteins, and functional ingredients with strong CDMO/private-label capabilities for sports and lifestyle nutrition brands. Its end markets, customer base (sports nutrition and supplement brands), and formulation-to-packaging service model closely parallel NAIE's private-label and CarnoSyn ingredient businesses.
• Aenova Group: Aenova is one of Europe's largest pharmaceutical and nutraceutical CDMOs, offering formulation, manufacturing, and packaging of solid dosage forms including tablets and capsules. It is directly comparable to NAIE in serving brand customers with private-label and contract manufacturing of dietary supplements across European and global markets.
• Sirio Pharma: Sirio Pharma is a global CDMO specializing in nutraceuticals, functional gummies, softgels, and beverage formats serving brand owners worldwide. Its full-service development, manufacturing, and packaging model — including its own proprietary ingredients — mirrors NAIE's contract manufacturing plus CarnoSyn-style branded ingredient strategy.
• Balchem Corporation: Balchem is a US-listed specialty ingredient manufacturer serving human nutrition and health & wellness markets with branded ingredient portfolios and encapsulation technology. Its model of combining proprietary functional ingredients with custom nutrient premix and encapsulation services is structurally similar to NAIE's combination of CarnoSyn branded ingredients with private-label contract manufacturing.

Emerging players

• AB Biotics: AB Biotics is a Spanish biotech that develops and manufactures proprietary probiotic and nutraceutical strains for supplement brands globally. It is an emerging specialty player whose branded ingredient-plus-CDMO model intersects with NAIE's proprietary CarnoSyn ingredient business and Swiss quality positioning.
• PharmaZell: PharmaZell is a European specialty CDMO focused on niche APIs and finished dosage forms including nutritional and health supplements. It is a smaller, emerging CDMO with comparable European GMP-certified manufacturing and formulation capabilities for health-product brands.

Broad incumbents

• Catalent: Catalent is a major global CDMO with broad dosage-form capabilities across pharmaceuticals and consumer health, including softgel and oral solid dose manufacturing. While much larger and more pharma-focused than NAIE, it competes for the same brand customers seeking outsourced development and manufacturing of supplements and OTC health products.
• Patheon (Thermo Fisher Scientific): Patheon, part of Thermo Fisher's pharma services segment, is one of the largest global CDMOs offering formulation and commercial manufacturing across solid, sterile, and softgel dosage forms. It competes with NAIE at the high end of the contract manufacturing market for brand customers needing turnkey development and production services.
• Lonza Group: Lonza is a Swiss-headquartered global CDMO with extensive nutrition and capsules businesses (Capsules & Health Ingredients) serving supplement brands. Its Swiss heritage, GMP-certified manufacturing, and proprietary capsule and ingredient portfolio make it a comparable but much larger incumbent operating in NAIE's core European CDMO and ingredient space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/natural-alternatives-international-europe

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Natural Alternatives International Europe SA